1201 studies found for:    Open Studies | "Genital Diseases, Male"
Show Display Options
Rank Status Study
21 Recruiting Phase 1 Study of GEN0101 in Patients With Recurrence of CRPC
Condition: Castration Resistant Prostate Cancer
Intervention: Drug: GEN0101
22 Recruiting Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer
Conditions: Health Status Unknown;   Prostate Carcinoma
Interventions: Procedure: 3 Tesla Magnetic Resonance Imaging;   Radiation: Gadodiamide;   Procedure: Multiparametric Magnetic Resonance Imaging;   Procedure: Transrectal Biopsy;   Procedure: Ultrasound-Guided Prostate Biopsy
23 Recruiting Modulation of Biomarkers in Patients With Flesh-eating Bacterial Infections After With Hyperbaric Oxygen Treatment
Conditions: Necrotizing Soft Tissue Infection;   Necrotizing Fasciitis;   Gas Gangrene;   Fournier Gangrene
Intervention:
24 Not yet recruiting Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC)
Condition: Metastatic Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Niraparib
25 Not yet recruiting Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
Conditions: Germ Cell Tumors;   Testicular Cancer;   Primary Mediastinal Non Seminomatous Germ Cell Tumors
Intervention: Drug: Pembrolizumab
26 Recruiting Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: PRX302
27 Recruiting Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Malignant Neoplasm in the Bone;   Metastatic Malignant Neoplasm in the Soft Tissues;   Metastatic Prostate Carcinoma;   Prostate Adenocarcinoma;   Recurrent Prostate Carcinoma;   Stage IV Prostate Cancer
Interventions: Biological: Pembrolizumab;   Biological: pTVG-HP Plasmid DNA Vaccine
28 Not yet recruiting A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: LY2452473;   Drug: Placebo
29 Not yet recruiting rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities
Condition: Sexually Transmitted Infection
Intervention: Behavioral: rPlan dual protection waiting room app intervention
30 Not yet recruiting Foreskin Graft Tubularized Incised Plate Urethroplasty vs Tubularized Incised Plate for Primary Hypospadias (FGTIP-TIP)
Condition: Hypospadias
Interventions: Procedure: Foreskin Graft-Tubularized Incised Plate;   Procedure: Tubularized Incised Plate
31 Not yet recruiting Safety and Clinical Efficacy of Local Topical Treatment for Erectile Dysfunction
Condition: Erectile Dysfunction
Intervention: Drug: VL#FIA3-30
32 Recruiting In Vitro Follicle Activation
Conditions: Primary Ovarian Insufficiency;   Infertility
Interventions: Procedure: In Vitro Follicle Activation (IVA);   Drug: Follicle Activation
33 Not yet recruiting Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan
Conditions: Prostatic Hyperplasia;   Kidney Calculi;   Bladder Tumors
Intervention: Device: Aqueduct
34 Not yet recruiting European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Condition: Metastatic Castration Resistant Prostate Cancer
Intervention: Drug: enzalutamide
35 Recruiting Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)
Condition: Erectile Dysfunction
Interventions: Drug: Glyceryl trinitrate;   Drug: MED Placebo
36 Not yet recruiting LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC
Condition: Prostate Cancer
Interventions: Drug: Docetaxel;   Drug: Ribociclib;   Drug: Prednisone;   Drug: Filgrastim
37 Not yet recruiting Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Degarelix;   Drug: Doxorubicin;   Drug: Ketoconazole;   Drug: Docetaxel;   Drug: Estramustine
38 Not yet recruiting The PK Characteristics of the JLP-1207(Solifenacin/Tamsulosin 5mg/0.2mg) and Co-administration of Solifenacin and Tamsulosin in Healthy Male Volunteers.
Conditions: LUTS(Lower Urinary Tract Symptoms);   Benign Prostatic Hyperplasia;   Overactive Bladder
Interventions: Drug: JLP-1207;   Drug: Solifenacin 5mg + Tamsulosin 0.2mg
39 Not yet recruiting Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Arteriogenic Erectile Dysfunction
Condition: Impotence, Arteriogenic
Intervention: Device: Bioabsorbable everolimus-eluting stent deployment
40 Not yet recruiting Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy
Conditions: Peripheral Nervous System Diseases;   Testicular Neoplasms
Interventions: Procedure: Blood sample collection;   Behavioral: Report of peripheral neuropathy after cisplatin therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years